{"id":"NCT01842607","sponsor":"GlaxoSmithKline","briefTitle":"A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects","officialTitle":"A Multi-centre, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects Who Participated in theMEA115588 or MEA115575 Trials","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05-27","primaryCompletion":"2015-03-13","completion":"2015-03-13","firstPosted":"2013-04-29","resultsPosted":"2016-03-03","lastUpdate":"2018-08-06"},"enrollment":651,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"BIOLOGICAL","name":"Mepolizumab","otherNames":[]}],"arms":[{"label":"Mepolizumab Arm","type":"EXPERIMENTAL"}],"summary":"This is a multi-centre, open-label long-term safety study of 100 milligram (mg) mepolizumab administered subcutaneously (SC) every 4 weeks for 12 months in addition to standard of care in subjects who have severe, refractory asthma and a history of eosinophilic inflammation. Subjects who completed either MEA115588 or MEA115575 will be offered the opportunity to consent for this study.","primaryOutcome":{"measure":"Number of Participants With Adverse Events (AEs) Including Both Systemic (i.e. Allergic/Immunoglobulin (Ig)E-mediated and Non-allergic) and Local Site Reactions","timeFrame":"From Baseline visit until the follow-up visit (approximately [approx.] week 60 [12 weeks post-last dose])","effectByArm":[{"arm":"Mepolizumab 100 mg SC","deltaMin":558,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":137,"countries":["United States","Argentina","Australia","Belgium","Canada","Chile","Czechia","France","Germany","Italy","Japan","Mexico","Netherlands","Poland","Russia","South Korea","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["34098955","31507641","31447130","30954640","27553751"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":94,"n":651},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Bronchitis","Sinusitis"]}}